Polydeoxyribonucleotide (PDRN) promotes human osteoblast proliferation: A new proposal for bone tissue repair

Life Sciences

Volumn 73, Issue 15, 2003, Pages 1973-1983

  Guizzardi, Stefano ^a   Galli, Carlo ^a   Govoni, Paolo ^a   Boratto, Renata ^b   Cattarini, Giulia ^c   Martini, Desiree ^d   Belletti, Silvana ^a   Scandroglio, Renato ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Mastelli Srl   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

DMPX; Osteoblast; Polydeoxyribonucleotide; Purinergic receptor

Indexed keywords

ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ALKALINE PHOSPHATASE; DEOXYRIBONUCLEOTIDE; DIMETHYLPROPARGYLXANTHINE; POLYRIBONUCLEOTIDE; SURAMIN; UNCLASSIFIED DRUG;

ARTICLE; BONE REGENERATION; BONE TISSUE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH STIMULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OSTEOBLAST; PROTEIN FUNCTION; TISSUE REPAIR;

EID: 0042704999     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00547-2     Document Type: Article

References (45)

1. Adjej A.A., Yamamoto S., Kulkarni A. Nucleic acid and /or their components: a possible role in immune function. Journal of Nutritional Science and Vitaminology. 41:1995;1-16.
2. Beresford J.N., Gallagher J.A., Poser J.W., Russel R.G.G. Production of osteocalcin by human bone cells in vitro. Effects of 1,25-(OH)2D3 24,25-(OH)2D3, parathyroid hormone, and glucocorticoids. Metabolic Bone Disease & Related Research. 5:1984;229-234.
3. Bianchini P., Tellini N., Morani A.M., Follano M.G. Pharmacological data on polydeoxyribonucleotide of human placenta. International Journal of Tissue Reactions. 3:1981;151-154.
4. Bigliardi P. Treatment of acute radiodermatitis of first and second degrees with semi-greasy placenta ointment. International Journal of Tissue Reactions. 4:1982;153-154.
5. Boden S.D. Bioactive factors for bone tissue engineering. Clinical Orthopaedics and Related Research. 367S:1999;84-94.
6. Born G.V., Kratzer M.A. Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. Journal Physiology (London). 354:1984;419-429.
7. Bourque W.T., Gross M., Hall B.K. Expression of four growth factors during fracture repair. The International Journal of Developmental Biology. 37:1993;573-579.
8. Bowler W.B., Buckley K.A., Gartland A., Hipskind R.A., Bilbe G., Gallagher J.A. Extracellular Nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling. Bone. 28(5):2001;507-512.
9. Bowler W.B., Dixon C.J., Halleux C., Maier R., Bilbe G., Fraser W.D., Gallagher J.A., Hipskind R.A. Signaling in human osteoblasts by extracellular nucleotides. Their weak induction of the c-fos oncogene via Ca2+ mobilization is strongly potentiated by a parathyroid hormone/cAMP-dependent protein kinase pathway indipendently of mitogen-activated protein kinase. Journal of Biological Chemistry. 274:1999;14315-14324.
10. Bruder S.P., Fox B.S. Tissue engineering of bone. Clinical Orthopaedic and Related Research. 367S:1999;S68-S83.
11. Canalis E., McCarthy T., Centerella M. Growth factors and the regulation of bone remodeling. Journal of Clinical Investigation. 81:1988;277-281.
12. Chavan A.J., Haley B.E. Interaction of nucleotides with acidic fibroblast growth factor (FGF-1). Biochemistry. 33:1994;193-7202.
13. Chin, J.E., 1984. Production and characterization of matrix vesicles by chicken epiphiseal growth plate chondrocytes in primary culture and regulation by physiological factors. Ph.D. Thesis, University of South, 166-168.
14. Ding Gji W., Ning-Na H., Heppel L.A. Extracellular ATP shows synergistic enhancement of DNA synthesis when combined with agents that are active in wound healing or as neurotransmitters. Biochemistry Biophysic Resesearch Communications. 166:1990;251-258.
15. Edington S.M. DNA and RNA therapeutics: unsolved riddles. Bio Technology. 10:1992;993-996.
16. Einhorn T.A. Enhancement of fracture healing. Instructional Course Lectures. 45:1996;401-416.
17. Farley J.R., Hall S.L., Tanner M.A., Wergedal J.E. Specific activity of scheletal alkaline phosphatase in human osteoblast-line cells regulated by phosphate, phosphate esters, and phosphate analogs and release of alkaline phosphatase activity inversely regulated by calcium. Journal of Bone Mineral Research. 9(4):1994;497-508.
18. Fedarko N.S., Bianco P., Vetter U., Gheron Robey P. Human bone celle enzyme expression and cellular heterogeneity: correlation of alkaline phosphatase enzyme activity with cell cycle. Journal of Cellular Phisiology. 144:1990;115-121.
19. Gailit J., Clarck A.F. Wound repair in the context of extracellular matrix. Current Opinion in Cell Biology. 6:1994;717-725.
20. Gallagher J.A., Gundle R., Beresford J. Isolation and culture of bone-forming cells (osteoblasts) from human bone. Jones G.E. Human Cell Culture Protocols. 1996;232-257 Humana Press, Totowa NJ.
21. Harakas N.K. Demineralized bone matrix-induced osteogenesis. Clinical Orthopaedic and Related Research. 188:1984;239-251.
22. Henning U.G., Wang Q., Gee N.H., Borstel R.C. Protection and repair of gamma radiation induced lesions in mice with DNA or deoxyribonucleotides treatments. Mutatation Research. 35:1996;25-30.
23. Jensen O.T., Shulman L.B., Block M.S., Iacono V.J. Report of the sinus consensus conference of 1996. International Journal of Oral Maxillofacial Implants. 13S:1998;11-45.
24. Joyce M.E., Jingushi S., Bolander M.E. Transforming growth factor beta in the regulation of fracture repair. The Orthopedic Clinics of North America. 21:1990;199-209.
25. Joyce M.E., Jingushi S., Scully S.P., Bolander M.E. Role of growth factors in in fracture healing. Progress in Clinical and Biological Research. 365:1991;391-416.
26. Lane J.M., Tomin E., Bostrom M.P.G. Biosynthetic bone grafting. Clinical Orthopaedic and Related Research. 367S:1999;107-117.
27. Lorenzetti M., Mozzati M., Campanino P.P., Valente G. Bone augmentation of the inferior floor of the maxillary sinus with autogenous bone or composite bone grafts: a Histologic-histomorphometric preliminary report. International Journal of Oral Maxillofacial Implants. 13(1):1998;69-76.
28. 2A receptors. American Journal of Pathology. 160:2002;2009-2018.
29. Muratore O., Pesce Schito A., Cattarini G., Tonoli E.L., Gianoglio S., Schiappacasse S., Felli L., Picchetta F., Schito G.G. Evaluation of the trophic effect of human placental polydeoxyribonucleotides on human knee skin fibroblasts in primary culture. Cellular Molecular Life Science. 53:1997;279-285.
30. Musk P., Campbell R., Staples J., Moss D., Parson P.G. Solar and UV induced mutation in human cells and inhibition by deoxyribonucleotids. Mutatation Research. 227:1989;25-30.
31. Nakamura E., Uezono Y., Narusawa K., Shibuya I., Oishi Y., Tanaka M., Yanaggihara N., Nakamura T., Izumi F. ATP activates DNA synthesis by acting on P2X receptors in human osteoblasts like MG-63 cells. American Journal of Physiology (Cell Physiology). 279(2):2000;C510-C519.
32. Ostrom R.S., Gregorian C., Insel P.A. Cellular release of and response to ATP as key determinants of set point of signal transduction pathways. Journal of Biological Chemistry. 16:2000;11735-11739.
33. Rathbone M.P., Christjanson L., De Forge S., Deluca B., Gysbers J.W., Hindley S., Jovetich M., Middlemiss P., Takal S. Extracellular purine nucleosides stimulate cell division and morphogenesis: pathological and physiological implications. Medical Hypothesis. 37:1992;232-240.
34. Rathbone M.P., De Forge S., Deluca B., Gabel B., Laurenssen C., Middlemiss P., Parkinson S. Purinergic stimulation of cell division and differentiation: mechanism and pharmacological implications. Medical Hypothesis. 37:1992;213-219.
35. Rathbone M.P., Middlemiss P.J., Gysbers J.W., De Forge S., Costello P., Del Maestro R.F. Purine nucleosides and nucleotides stimulate proliferation of a wide range of cells in vitro. In Vitro Cellular & Developmental Biology. Journal of the Tissue Culture Association. 28A:1992;529-536.
36. Reddi A.H. Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Current Opinion in Cellular Biology. 4:1992;850-855.
37. Service R.F. Tissue engineers build new bone. Science. 289:2000;1497-1500.
38. Siggelkow H., Hilmes D., Rebenstorff K., Kurre W., Huefner M. Analysis of human primary bone cells by fluorescence activated cell scanning: methodological problems and preliminary results. Clinica Chimica Acta; International Journal of Clinical Chemistry. 272:1998;111-125.
39. Sini P., Denti A., Cattarini G., Daglio M., Tira M.E., Balduini C. Effect of polydeoxyribonucleotides on human fibroblasts in primary culture. Cell Biochemistry and Function. 17:1999;107-114.
40. 2 purinergic receptor subtypes. Life Sciences. 64(18):1999;1661-1674.
41. Tonello G., Daglio M., Zaccarelli N., Sottofattori E., Mazzei B., Balbi A. Characterization and quantitation of the active polynucleotide fraction (PDRN) from human placenta, a tissue repair stimulating agent. Journal of Pharmaceutical and Biomedical Analysis. 14:1996;1555-1560.
42. Urist M.R. Bone: formation by autoinduction. Science. 150:1965;893-899.
43. Urist M.R., Strates B.S. Bone morphogenetic protein. Journal of Dental Research. 50S:1971;1392-1406.
44. 2A receptor agonists promote more rapid wound healng than recombinant human platelet derived growth factor (Beclaplermin Gel). Inflammation. 26(1):2002;19-24.
45. Viassov V.V., Balakireva L.A., Yabukov L.A. Transport of oligonucleotides across natural and model membranes. Biochimica et Biophysica Acta. 1197:1994;95-108.